Ocugen, Inc.OCGNNASDAQ
Loading
R&D Expense Growth AcceleratingAccelerating
Percentile Rank69
3Y CAGR-26.6%
5Y CAGR-18.3%
Year-over-Year Change
Year-over-year research & development expense growth
3Y CAGR
-26.6%/yr
vs +242.3%/yr prior
5Y CAGR
-18.3%/yr
Recent deceleration
Acceleration
-268.9pp
Decelerating
Percentile
P69
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
2 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 23.73% |
| 2024 | -18.82% |
| 2023 | -29.53% |
| 2022 | 59.96% |
| 2021 | 162.90% |
| 2020 | 65.15% |
| 2019 | -48.28% |
| 2018 | 0.44% |
| 2017 | -27.86% |
| 2016 | -7.17% |